Oculis Holding AG Ordinary shares (OCS)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $425.67M
Last updated: Nov 17, 2026 at 11:05 AM ET
Oculis Holding AG Ordinary shares (OCS) Financials: Revenue, Profit and Cash Flow
Oculis Holding AG Ordinary shares reported revenue of CHF 0 for the fiscal year ended Dec 31, 2025, down 100.0% from the year before. That year, net income was CHF -94.51M, operating cash flow was CHF -62.22M and free cash flow was CHF -62.51M. The quarter ended Sep 30, 2026 had revenue of CHF 7.00K and net income of CHF -18.24M.
Revenue and Margins
The company reported no revenue in the fiscal year ended Dec 2025, with an operating loss of CHF 79.15M.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | 0 | -100.0% | N/A | N/A | N/A |
| Dec 2024 | 686.00K | -22.3% | -7492.3% | -10671.1% | -12503.9% |
| Dec 2023 | 883.00K | -3.2% | -3212.2% | -9140.9% | -10056.9% |
| Dec 2022 | 912.00K | -5.0% | -2336.8% | -3550.0% | -4243.2% |
| Dec 2021 | 960.00K | -3.3% | -896.7% | -1378.3% | -1932.5% |
| Dec 2020 | 993.00K | N/A | -840.3% | -1242.3% | -1497.8% |
Income Statement
In the fiscal year ended Dec 2025, the net loss widened from the year before. In the quarter ended Sep 2026, the net loss widened from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 686.00K | 883.00K | 912.00K | 960.00K | 993.00K |
| Cost of revenue | N/A | 52.08M | 29.25M | 22.22M | 9.57M | 9.34M |
| Gross profit | N/A | -51.40M | -28.36M | -21.31M | -8.61M | -8.34M |
| Research and development | 54.52M | 52.08M | 29.25M | 22.22M | 9.57M | 9.34M |
| Operating income | -79.15M | -73.20M | -80.71M | -32.38M | -13.23M | -12.34M |
| Net income | -94.51M | -85.78M | -88.80M | -38.70M | -18.55M | -14.87M |
| EBITDA | N/A | N/A | N/A | -31.90M | -13.17M | -12.10M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7.00K | 0 | 0 | 0 | 243.00K | 261.00K | 0 | 0 | 0 | 245.00K | 222.00K | 185.00K |
| Gross profit | 7.00K | N/A | -157.43K | N/A | 243.00K | -14.65M | N/A | N/A | N/A | -16.22M | -10.63M | -7.84M |
| Operating income | -23.64M | -23.57M | -22.43M | -20.88M | -20.30M | -20.77M | -19.97M | -17.26M | -18.13M | -22.48M | -15.33M | -12.18M |
| Net income | -18.24M | -9.97M | -29.50M | -23.34M | -16.86M | -25.38M | -33.21M | -28.66M | -20.19M | -20.84M | -16.09M | -12.50M |
Balance Sheet
As of Dec 2025, cash and equivalents exceeded short-term debt of CHF 502.57K by 80.92M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
| Total assets | 236.23M | 120.35M | 114.35M | 37.06M | 58.04M | 16.38M |
| Current assets | 219.14M | 104.90M | 101.02M | 23.66M | 47.98M | 6.16M |
| Cash and equivalents | 81.42M | 27.71M | 38.33M | 19.79M | 46.28M | 4.95M |
| Total liabilities | 39.94M | 46.97M | 20.63M | 135.05M | 119.00M | 60.04M |
| Short-term debt | 502.57K | 315.00K | 174.00K | 142.00K | 193.00K | 188.00K |
| Long-term debt | N/A | N/A | N/A | 122.45M | 113.50M | 53.98M |
| Shareholder equity | 196.29M | 73.38M | 93.73M | -97.99M | -60.95M | -43.65M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 232.32M | 250.34M | 243.26M | 236.23M | 167.84M | 181.62M | 204.17M | 120.35M | 125.61M | 138.73M | 98.71M | 114.35M |
| Total liabilities | 23.57M | 31.00M | 47.20M | 39.94M | 37.24M | 38.52M | 41.55M | 46.97M | 30.38M | 25.91M | 19.68M | 20.63M |
| Cash and equivalents | 66.29M | 8.00K | 64.37M | 81.42M | 46.44M | 64.27M | 59.87M | 27.71M | 35.63M | 43.85M | 24.36M | 38.33M |
| Shareholder equity | 208.75M | 219.34M | 196.06M | 196.29M | 130.59M | 143.10M | 162.63M | 73.38M | 95.23M | 112.83M | 79.03M | 93.73M |
Cash Flow
Operating cash flow was negative in the fiscal year ended Dec 2025.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | -62.22M | -47.50M | -53.84M | -25.07M | -13.82M | -12.03M |
| Capital expenditures | 287.47K | 230.00K | 48.00K | 3.55M | 28.00K | 19.00K |
| Free cash flow | -62.51M | -47.73M | -53.89M | -28.62M | -13.85M | -12.05M |
| Investing cash flow | -59.38M | -17.56M | -54.21M | -3.55M | -28.00K | -19.00K |
| Financing cash flow | 178.60M | 54.03M | 129.67M | 1.71M | 55.19M | 4.86M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -18.96M | -20.23M | -15.54M | -16.68M | -13.42M | -17.24M | -18.96M | -10.36M | -10.43M | -13.52M | -13.72M | -13.02M |
| Capital expenditures | N/A | 14.00K | 7.16K | 38.00K | 124.00K | 126.00K | 1.10M | 57.00K | 154.00K | 19.00K | 3 | 5.00K |
| Free cash flow | N/A | -20.25M | -15.54M | -16.72M | -13.54M | -17.37M | -20.06M | -10.41M | -10.59M | -13.53M | -13.72M | -13.02M |
Frequently Asked Questions About OCS
What is Oculis Holding AG Ordinary shares' annual revenue?
Oculis Holding AG Ordinary shares reported revenue of CHF 0 for the fiscal year ended Dec 31, 2025.
How fast is Oculis Holding AG Ordinary shares' revenue growing?
Revenue was down 100.0% for the fiscal year ended Dec 31, 2025 compared with the year before.
Is Oculis Holding AG Ordinary shares profitable?
No. Oculis Holding AG Ordinary shares reported net income of CHF -94.51M for the fiscal year ended Dec 31, 2025.
How much free cash flow does OCS generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of CHF -62.22M minus capital expenditures of CHF 287.47K produced free cash flow of CHF -62.51M.
How much debt does Oculis Holding AG Ordinary shares have?
The balance sheet dated Dec 31, 2025 reported short-term debt of CHF 502.57K and cash and equivalents of CHF 81.42M.
OCS pages: Overview, Financials, Competitors